Curaleaf Issues Fact Sheet to Address Allegedly Misleading Statements from Aurora
Curaleaf Holdings issued a fact sheet refuting statements made by competitor Aurora Cannabis regarding Curaleaf's acquisition proposal. The filing highlights that the offer includes a 45% premium and emphasizes Aurora's financial underperformance and strategic challenges.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day